Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 12/2016

01-12-2016 | Retraction Note

Retraction Note to: Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma

Authors: Mohsen Mohammadi, Peyman Karimi Goudarzi, Omid Rahmani, Peyman Kaghazian, Emad Yahaghi, Afshin Taheriazam, Koroosh Ahmadi

Published in: Tumor Biology | Issue 12/2016

Login to get access

Excerpt

Retraction Note to: Tumor Biol (2016) 37:8153–8157 …
Metadata
Title
Retraction Note to: Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma
Authors
Mohsen Mohammadi
Peyman Karimi Goudarzi
Omid Rahmani
Peyman Kaghazian
Emad Yahaghi
Afshin Taheriazam
Koroosh Ahmadi
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5485-0

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue

Original Article

RETRACTED ARTICLE: MiR-200 suppresses metastases of colorectal cancer through ZEB1

Original Article

MicroRNA-153 inhibits tumor progression in esophageal squamous cell carcinoma by targeting SNAI1

Original Article

E2F-1 promotes DAPK2-induced anti-tumor immunity of gastric cancer cells by targeting miR-34a

Original Article

RETRACTED ARTICLE: Effects of RNAi-mediated TUSC3 silencing on radiation-induced autophagy and radiation sensitivity of human lung adenocarcinoma cell line A549 under hypoxic condition

Original Article

Reduced decorin expression in the tumor stroma correlates with tumor proliferation and predicts poor prognosis in patients with I–IIIA non-small cell lung cancer

Original Article

RETRACTED ARTICLE: miR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits